Michael Soroka’s one-year, $9 million deal with the Washington Nationals is an intriguing move, but it comes with mixed reactions, both from fans and analysts. While Soroka struggled with a 0-10 record and a 4.74 ERA last season with the Chicago White Sox, his potential in a starting role could be a gamble worth taking for the Nationals, who are building around a young core and still in a rebuilding phase.
Why It’s an Interesting Move:
- Fresh Start: Soroka has battled injuries throughout his career, missing the 2021 and 2022 seasons due to an Achilles tendon injury. His ability to bounce back after such setbacks and contribute out of the bullpen with a 2.75 ERA shows resilience. A move back to the rotation could give him a chance to rediscover his form, especially with the Nationals’ relatively young and unproven starting staff.
- Potential to Help the Nationals: Washington’s starting rotation is still in development, with key players like Cade Cavalli and Josiah Gray rehabbing from Tommy John surgeries. Soroka could provide some much-needed stability and veteran presence in a rotation that includes young arms like Jake Irvin, MacKenzie Gore, DJ Herz, and Mitchell Parker.
Fans’ Concerns:
- Mixed Performance: While Soroka showed promise in the bullpen, his performance as a starter in 2024 was underwhelming, leading to many questioning the wisdom of paying him $9 million. Some fans argue that his record and stats last season, particularly as a starter, don’t justify such a significant commitment.
- Risk Factor: Soroka’s injury history also looms large. With a 0-10 record as a starter and a season cut short by surgery, it’s understandable that many fans are skeptical of his ability to stay healthy and effective in a starting role for a full season.
Nationals’ Long-Term Goals:
The Nationals are in a rebuilding phase, and while they aren’t expected to be major contenders in the short term, they are betting on their young talent for 2025 and beyond. Soroka’s contract is a low-risk move for the team, offering a chance for him to prove himself and contribute to a rotation that still needs a lot of development.
Conclusion:
While the $9 million contract may seem excessive given Soroka’s struggles and injury history, it’s a relatively low-risk signing for the Nationals, who have the flexibility to explore options while focusing on their long-term rebuild. Soroka’s performance in 2025 will likely be a big factor in determining whether this deal was a smart move for both him and the Nationals. Fans may be cautious, but the potential reward could outweigh the risks if Soroka finds his form again.
